Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

November

8

AlphaTec Reports Third Quarter 2018 Financial and Corporate Highlights

Results for the third quarter ended September 30, 2018 and corporate highlight CARLSBAD, Calif., Nov....

7

TriSalus Life Sciences’ Pressure-Enabled Drug Delivery (PEDD) Significantly Increased Therapeutic Effect of Anti-CEA CAR-T in Pancreatic Cancer Patients with Liver Metastases

PEDD overpowers intratumoral high pressure, significantly increasing CAR-T into solid tumors Median overall survival...

1

SupplyPro® Unveils New SupplySystem Intelligent Software™ for Inventory Management

SupplySystem IS Leverages Advanced Technologies to Deliver a Competitive Advantage SAN DIEGO – November...

26

TriSalus Life Sciences Names Chief Business Officer

Leadership appointment supports strategic shift to build oncology drug delivery company TriSalus Life Sciences...

23

Nice Publishes Advice on GammaCore for the Treatment of Cluster Headache in the UK

Report contributors agreed gammaCore was highly innovative, may be more effective than standard of...

12

Exagen Announces Launch of Novel Biomarker PC4D Asociated with Thrombosis in Lupus

Makers of the rapidly growing AVISE CTD test expands portfolio of patented CB-CAPs blood...

4

OrthoSensor Announces Milestone of 50,000 VeraSense™ Sensors Distributed Globally

10/04/2018 VERASENSE is transforming primary and revision total knee replacement for surgeons and patients...

2

Exagen Featured in Eight Scientific Presentations at the 2018 ACR/ARHP Annual Meeting in Chicago

Leading immunology laboratory continues strides with first ever economic impact data for AVISE Lupus...

27

AlphaTec Accelerates Organic Innovation Machine with Addition of Key Senior Leadership and Expansion of Market

Mark Ojeda to lead Cervical and Biologics CARLSBAD, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) — Alphatec Holdings,...

26

AlphaTec Advances Clinical Distinction with OsseoCrew® Clearance

Alphatec’s OsseoScrew® System received 510(k) clearance from the U.S. Food & Drug Administration (FDA), making it available for clinical...

12

SureFire Medical to Change Name to TriSalus Life Sciences

New company name better represents contribution to patient care DENVER, Sept. 12, 2018 – Surefire...

11

Exagen, Maker of Avise Testing, Announces First Blood Test for AntiCarp, a Breakthrough Biomarker for Rheumatoid Arthritis

Novel test now available to aid in detection and management of widespread debilitating condition...

Recent developments

News

November

8

AlphaTec Reports Third Quarter 2018 Financial and Corporate Highlights

November

7

TriSalus Life Sciences’ Pressure-Enabled Drug Delivery (PEDD) Significantly Increased Therapeutic Effect of Anti-CEA CAR-T in Pancreatic Cancer Patients with Liver Metastases

November

1

SupplyPro® Unveils New SupplySystem Intelligent Software™ for Inventory Management

October

26

TriSalus Life Sciences Names Chief Business Officer

October

23

Nice Publishes Advice on GammaCore for the Treatment of Cluster Headache in the UK

October

12

Exagen Announces Launch of Novel Biomarker PC4D Asociated with Thrombosis in Lupus

October

4

OrthoSensor Announces Milestone of 50,000 VeraSense™ Sensors Distributed Globally

October

2

Exagen Featured in Eight Scientific Presentations at the 2018 ACR/ARHP Annual Meeting in Chicago

September

27

AlphaTec Accelerates Organic Innovation Machine with Addition of Key Senior Leadership and Expansion of Market

September

26

AlphaTec Advances Clinical Distinction with OsseoCrew® Clearance

September

12

SureFire Medical to Change Name to TriSalus Life Sciences

September

11

Exagen, Maker of Avise Testing, Announces First Blood Test for AntiCarp, a Breakthrough Biomarker for Rheumatoid Arthritis